Indivior Pharmaceuticals Inc
INDV
Pozycja w akcjach
#3838
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged... Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Cena akcji
$34.70
Kapitalizacja rynkowa
$4.33B
Zmiana (1 dzień)
-0.20%
Zmiana (1 rok)
44.04%
Kraj
US
Handel Indivior Pharmaceuticals Inc (INDV)
Kategoria
Healthcare
Historia ceny akcji dla Indivior Pharmaceuticals Inc (INDV)
Najwyższa cena zamknięcia: $35.03 dnia 2026-10-01
Najniższa cena zamknięcia: $10.90 dnia 2014-12-01
Najniższa cena zamknięcia: $10.90 dnia 2014-12-01
Historia cen akcji firmy Indivior Pharmaceuticals Inc od 2014 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | -1.48% |
| 2025 | 202.98% |
| 2024 | -23.97% |
| 2023 | -28.64% |
| 2022 | 35.86% |
| 2021 | 132.41% |
| 2020 | 154.62% |
| 2019 | -56.62% |
| 2018 | -76.25% |
| 2017 | 41.62% |
| 2016 | 30.92% |
| 2015 | 29.04% |
| 2014 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
